Cyberonics VNS Holds Up Against Depression In Two-Year Pilot Trial
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics' 60-patient pilot study of vagus nerve stimulation (VNS) for depression showed a 45% response rate at one year compared to 31% at the end of a 12-week acute phase